國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Targeting the IL-17 pathway in infla...

Chu, Cong-Qiu.

Targeting the IL-17 pathway in inflammatory disorders

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Targeting the IL-17 pathway in inflammatory disordersby Cong-Qiu Chu.
作者:	Chu, Cong-Qiu.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	xv, 102 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Interleukins.
電子資源:	http://dx.doi.org/10.1007/978-3-319-28040-0
ISBN:	9783319280400$q(electronic bk.)

Targeting the IL-17 pathway in inflammatory disorders
Chu, Cong-Qiu.

Targeting the IL-17 pathway in inflammatory disorders[electronic resource] /by Cong-Qiu Chu. - Cham :Springer International Publishing :2017. - xv, 102 p. :ill., digital ;24 cm.

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

ISBN: 9783319280400$q(electronic bk.)

Standard No.: 10.1007/978-3-319-28040-0doiSubjects--Topical Terms:

747213
Interleukins.

LC Class. No.: QR185.8.I56

Dewey Class. No.: 571.96

Targeting the IL-17 pathway in inflammatory disorders
LDR:01685nmm a2200301 a 4500 001 505787
003 DE-He213
005 20161128200532.0
006 m d
007 cr nn 008maaau
008 171030s2017 gw s 0 eng d
020 $a 9783319280400$q(electronic bk.)
020 $a 9783319280394$q(paper)
024 7 $a 10.1007/978-3-319-28040-0 $2 doi
035 $a 978-3-319-28040-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR185.8.I56
072 7 $a MJM $2 bicssc
072 7 $a MED083000 $2 bisacsh
082 0 4 $a 571.96 $2 23
090 $a QR185.8.I56 $b C559 2017
100 1 $a Chu, Cong-Qiu. $3 771340
245 1 0 $a Targeting the IL-17 pathway in inflammatory disorders $h [electronic resource] / $c by Cong-Qiu Chu.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2017.
300 $a xv, 102 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
650 0 $a Interleukins. $3 747213
650 0 $a Inflammation. $3 250775
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Rheumatology. $3 276701
650 2 4 $a Dermatology. $3 274951
650 2 4 $a Pharmacotherapy. $3 615025
650 2 4 $a Primary Care Medicine. $3 275823
650 2 4 $a Public Health. $3 320661
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-28040-0
950 $a Medicine (Springer-11650)